The intestinal protozoan parasite Giardia lamblia is a major cause of persistent diarrhea in humans and animals worldwide. Treatment of giardiasis with nitro-prodrugs relies on intrinsic enzymes in G.lamblia that are involved in activating or deactivating the prodrugs. To elucidate more about the physiologic function of these pathways and their potential roles in drug resistance, G.lamblia wildtype and transgenic strains were metabolomically characterized based on 1H HR-MAS NMR data and specific metabolites that may be related to nitroreductase activity were identified and discussed.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords